SWEDEN- Industrifonden sells shares in XCounter

XCounter’s first product, XC Mammo-3T, is used in digital mammography for breast cancer screening. The product enables 3D images at lower levels of radiation doses, with higher image quality and at competitive production costs when compared to the technology currentky available.

HealthCap was one of the first investors in the company, and first invested in the business in 1998. SEB Företagsinvest led a second round of funding in 2000. In 2002, XCounter received € 21.2m in a third round led by Abingworth and including new investors Dansk Kapitalanlæg, Alafi Capital, Optiomi and Concordia Capital, and existing investors HealthCap, SEB Företagsinvest, Industrifonden and MVI.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Exits
• Nordics